Does DACLIZUMAB Cause Pustular psoriasis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Pustular psoriasis have been filed in association with DACLIZUMAB. This represents 0.3% of all adverse event reports for DACLIZUMAB.
8
Reports of Pustular psoriasis with DACLIZUMAB
0.3%
of all DACLIZUMAB reports
7
Deaths
4
Hospitalizations
How Dangerous Is Pustular psoriasis From DACLIZUMAB?
Of the 8 reports, 7 (87.5%) resulted in death, 4 (50.0%) required hospitalization, and 5 (62.5%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLIZUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DACLIZUMAB Cause?
Alopecia (450)
Transplant dysfunction (421)
Transplant rejection (385)
Acne (382)
Ovarian cyst (374)
Multiple sclerosis relapse (313)
Drug ineffective (229)
Pain (224)
Pneumonia (213)
Condition aggravated (172)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
Which DACLIZUMAB Alternatives Have Lower Pustular psoriasis Risk?
DACLIZUMAB vs DACOMITINIB
DACLIZUMAB vs DACTINOMYCIN
DACLIZUMAB vs DALBAVANCIN
DACLIZUMAB vs DALFAMPRIDINE
DACLIZUMAB vs DALTEPARIN